Chinese health-focused 111 Inc. said the company is on the same page with Chinese government to tackle the country’s long-existing medical problems and help consolidate the pharmacy industry. The company went public last week in the US, raising US$100.5 million by selling 7.7 million American Depository Shares (ADS) at US$14 apiece, lower end of its target price range of US$14 to US$16 per share. The company’s flotation came at a time when China’s general health and wellness market is booming. The market …

111 Inc.’s Xu Weihao: Online Healthcare Platform With Govt To Tackle China’s Medical Problems appeared first on China Money Network.